Epilepsy Market Share

North American Market Forecast   

The North America epilepsy market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed to the increasing prevalence of epilepsy in the region. It is estimated that over 1.2% of the total US population had active epilepsy. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to opt for easy testing of epilepsy drugs over a large target population is also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising healthcare expenditure are also anticipated to boost market growth during the forecast period.

APAC Market Statistics

On the other hand, the Asia Pacific epilepsy market is also projected to grow at a significant pace with a notable CAGR rate. The growth of the market in the region can be attributed to similar factors, such as rising cases of neurological diseases and a growing geriatric population with various types of brain disorders. Also, the rapid growth of the healthcare industry and rising investment in enhancing the healthcare system are other factors that are anticipated to create a positive outlook for generating significant revenue in the forecast period. Moreover, the presence of a large pool of patients and the rapid escalation of non-communicable diseases are also expected to create a positive outlook in the upcoming years.